| Literature DB >> 12057130 |
A Daud1, P Munster, P Munster, D R Spriggs.
Abstract
The implementation of new drug treatments has improved the prognosis for advanced cancers of the cervix, uterus, and ovary. Platinum analogs are the most effective drugs in the treatment of ovarian cancer. Other drugs, such as oxaliplatin, have been proposed as a rational treatment of platinum refractory ovarian cancer. Epothilones are also being studied in clinical trials, as are histone deacetylase inhibitors. Several promising agents may soon receive Food and Drug Administration approval.Entities:
Mesh：
Substances：
Year: 2001 PMID： 12057130 DOI： 10.1007/s11864-001-0054-0
Source DB: PubMed Journal: Curr Treat Options Oncol ISSN： 1534-6277